Illumina expands MRD research portfolio with ultrasensitive sequencing technology

Photocure maintains 2028 Medicare coverage target for AssureMDx following CMS update

RYBREVANT FASPRO co-formulated with Halozyme's ENHANZE technology approved by US FDA in advanced head and neck cancer

Akeso publishes ivonescimab Phase II study results in Nature Medicine

INOVIO prices public offering of approximately USD75m

First patient dosed in Phase 1 trial of Transgene and BioInvent's BT-001 for rectal cancer

Elicera Therapeutics secures Chinese patent allowance for ELC-401

CHOSA Oncology signs US laboratory agreement for Platin-DRP commercialisation

BeOne Medicines wins FDA Priority Review for BRUKINSA combination in first-line mantle cell lymphoma

Pentixapharm advances preparationsfor Phase 3 PANDA study

CStone and Kimia Therapeutics collaborate to advance oncology drug candidate

Vivesto secures US orphan drug designation for Cantrixil in acute myeloid leukemia

Lytix Biopharma's ruxotemitide combination meets primary endpoint in Phase II melanoma trial

INOVIO's VOCERYQ receives US FDA accelerated approval to reduce surgery frequency in adults with RRP

Phrontline Biopharma reports preliminary safety and antitumour activity for TJ101